Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 599.00
-12.00 (-1.96%)
Jun 24, 2026, 10:42 AM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 24.81 billion as of June 23, 2026. Its market cap has increased by 4.44% in one year.
Market Cap
24.81B
Enterprise Value
21.56B
Revenue
2.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
599.00
Market Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 24.81B, an increase of 314.07%. That is a compound annual growth rate of 7.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 24.81B | -1.77% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healios K.K. | 33.08B |
| Cuorips | 31.21B |
| Renascience | 22.97B |
| StemRIM | 18.68B |
| AnGes | 18.67B |
| RaQualia Pharma | 12.39B |
| ReproCELL | 11.59B |
| Stella Pharma | 11.25B |